7mqx
From Proteopedia
(Difference between revisions)
| (One intermediate revision not shown.) | |||
| Line 3: | Line 3: | ||
<StructureSection load='7mqx' size='340' side='right'caption='[[7mqx]], [[Resolution|resolution]] 1.91Å' scene=''> | <StructureSection load='7mqx' size='340' side='right'caption='[[7mqx]], [[Resolution|resolution]] 1.91Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'> | + | <table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7MQX OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7MQX FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=ZMD:(3S)-2,1-benzoxaborole-1,3(3H)-diol'>ZMD</scene | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.914Å</td></tr> |
| - | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=MG:MAGNESIUM+ION'>MG</scene>, <scene name='pdbligand=ZMD:(3S)-2,1-benzoxaborole-1,3(3H)-diol'>ZMD</scene></td></tr> | |
| - | + | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7mqx FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7mqx OCA], [https://pdbe.org/7mqx PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7mqx RCSB], [https://www.ebi.ac.uk/pdbsum/7mqx PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7mqx ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7mqx FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7mqx OCA], [https://pdbe.org/7mqx PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7mqx RCSB], [https://www.ebi.ac.uk/pdbsum/7mqx PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7mqx ProSAT]</span></td></tr> | ||
</table> | </table> | ||
| - | <div style="background-color:#fffaf0;"> | ||
| - | == Publication Abstract from PubMed == | ||
| - | o-Carbonyl arylboronic acids such as 2-formylphenylboronic acid (2-FPBA) are employed in biocompatible conjugation reactions with the resulting iminoboronate adduct stabilized by an intramolecular N-B interaction. However, few studies have utilized these reagents as active site-directed enzyme inhibitors. We show that 2-FPBA is a potent reversible, slow-onset inhibitor of mandelate racemase (MR), an enzyme that has served as a valuable paradigm for understanding enzyme-catalyzed abstraction of an alpha-proton from a carbon acid substrate with a high pKa. Kinetic analysis of the progress curves for the slow onset of inhibition of wild-type MR using a two-step kinetic mechanism gave Ki and Ki* values of 5.1 +/- 1.8 and 0.26 +/- 0.08 muM, respectively. Hence, wild-type MR binds 2-FPBA with an affinity that exceeds that for the substrate by approximately 3000-fold. K164R MR was inhibited by 2-FPBA, while K166R MR was not inhibited, indicating that Lys 166 was essential for inhibition. Unexpectedly, mass spectrometric analysis of the NaCNBH3-treated enzyme-inhibitor complex did not yield evidence of an iminoboronate adduct. (11)B nuclear magnetic resonance spectroscopy of the MR.2-FPBA complex indicated that the boron atom was sp(3)-hybridized (delta 6.0), consistent with dative bond formation. Surprisingly, X-ray crystallography revealed the formation of an N(zeta)-B dative bond between Lys 166 and 2-FPBA with intramolecular cyclization to form a benzoxaborole, rather than the expected iminoboronate. Thus, when o-carbonyl arylboronic acid reagents are employed to modify proteins, the structure of the resulting product depends on the protein architecture at the site of modification. | ||
| - | + | ==See Also== | |
| - | + | *[[Mandelate racemase|Mandelate racemase]] | |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: Bacillus fluorescens putidus flugge 1886]] | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
| - | + | [[Category: Bearne SL]] | |
| - | [[Category: Bearne | + | [[Category: Grandinetti L]] |
| - | [[Category: Grandinetti | + | [[Category: StMaurice M]] |
| - | [[Category: | + | |
| - | + | ||
| - | + | ||
| - | + | ||
| - | + | ||
Current revision
P. putida mandelate racemase forms an oxobenzoxaborole adduct with 2-formylphenylboronic acid
| |||||||||||
